The Collagen & Hyaluronic Acid Company
Maxigen Biotech Inc., as a specialist in the medical device industry, offers innovative products from five disciplines and is certified by CE, FDA, NMPA, and MDSAP product certifications. We are committed to using science to join and delight human life. Join our mission.
About MBI
Maxigen Biotech Inc. (MBI) was founded in December 1998. Next year, MBI stationed at National Yang-Ming University and set up an incubation center at there to conduct the R&D work of collagen.
MBI utilizes its core competence in biopolymers and has developed a broad range of applications in areas such as medical devices and skincare products. MBI has been dedicated to the development and application medical device of collagen and hyaluronic acid.
Headquarters was moved to Hwa-Ya Technology park in July 2016. Our major shareholders include TCI Bio, GIH Group, and – NuVasive Inc., a Nasdaq-listed medical device company in the US.
History
- TCI Co.,Ltd became the largest shareholder,and Mr. Vincent Lin has been elected as the Chairman Formosa Biomedical Technology Crop. to invest via private placement.
- Formosa Biomedical Technology Corp. to invest via private placement.
Global Footprint
About TCI Group
We joined the TCI Group in 2021, which covers health food, medical devices, genetic testing, daily products, and pet health food. With the concept of “creating an integrated bioscience design trading company,” we are committed to expanding various upstream and downstream areas of life, health, and consumption to form a dense network.
